These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25043591)

  • 21. Pharmacologically targeting beta-catenin for NF1 associated deficiencies in fracture repair.
    Baht GS; Nadesan P; Silkstone D; Alman BA
    Bone; 2017 May; 98():31-36. PubMed ID: 28254468
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Pucciarelli D; Angus SP; Huang B; Zhang C; Nakaoka HJ; Krishnamurthi G; Bandyopadhyay S; Clapp DW; Shannon K; Johnson GL; Nakamura JL
    Mol Cancer Ther; 2020 Nov; 19(11):2382-2395. PubMed ID: 32847978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ras dependent paracrine secretion of osteopontin by Nf1+/- osteoblasts promote osteoclast activation in a neurofibromatosis type I murine model.
    Li H; Liu Y; Zhang Q; Jing Y; Chen S; Song Z; Yan J; Li Y; Wu X; Zhang X; Zhang Y; Case J; Yu M; Ingram DA; Yang FC
    Pediatr Res; 2009 Jun; 65(6):613-8. PubMed ID: 19247213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence.
    Nissan MH; Pratilas CA; Jones AM; Ramirez R; Won H; Liu C; Tiwari S; Kong L; Hanrahan AJ; Yao Z; Merghoub T; Ribas A; Chapman PB; Yaeger R; Taylor BS; Schultz N; Berger MF; Rosen N; Solit DB
    Cancer Res; 2014 Apr; 74(8):2340-50. PubMed ID: 24576830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurofibromin plays a critical role in modulating osteoblast differentiation of mesenchymal stem/progenitor cells.
    Wu X; Estwick SA; Chen S; Yu M; Ming W; Nebesio TD; Li Y; Yuan J; Kapur R; Ingram D; Yoder MC; Yang FC
    Hum Mol Genet; 2006 Oct; 15(19):2837-45. PubMed ID: 16893911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ras-Mek-Erk signaling regulates Nf1 heterozygous neointima formation.
    Stansfield BK; Bessler WK; Mali R; Mund JA; Downing BD; Kapur R; Ingram DA
    Am J Pathol; 2014 Jan; 184(1):79-85. PubMed ID: 24211110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of Receptor Tyrosine Kinases Mediates Acquired Resistance to MEK Inhibition in Malignant Peripheral Nerve Sheath Tumors.
    Wang J; Pollard K; Calizo A; Pratilas CA
    Cancer Res; 2021 Feb; 81(3):747-762. PubMed ID: 33203698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.
    Ioannou M; Lalwani K; Ayanlaja AA; Chinnasamy V; Pratilas CA; Schreck KC
    Mol Cancer Ther; 2024 Sep; 23(9):1261-1272. PubMed ID: 38714355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning.
    Yu X; Chen S; Potter OL; Murthy SM; Li J; Pulcini JM; Ohashi N; Winata T; Everett ET; Ingram D; Clapp WD; Hock JM
    Bone; 2005 May; 36(5):793-802. PubMed ID: 15804420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in
    Grenda A; Krawczyk P; Targowska-Duda KM; Kieszko R; Paśnik I; Milanowski J
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.
    Wang W; Nyman JS; Moss HE; Gutierrez G; Mundy GR; Yang X; Elefteriou F
    J Bone Miner Res; 2010 Jul; 25(7):1658-67. PubMed ID: 20200958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression.
    Leskelä HV; Kuorilehto T; Risteli J; Koivunen J; Nissinen M; Peltonen S; Kinnunen P; Messiaen L; Lehenkari P; Peltonen J
    Bone; 2009 Feb; 44(2):243-50. PubMed ID: 19061981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.
    Williams KB; Largaespada DA
    Genes (Basel); 2020 Apr; 11(5):. PubMed ID: 32353955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.
    Wu X; Chen S; He Y; Rhodes SD; Mohammad KS; Li X; Yang X; Jiang L; Nalepa G; Snider P; Robling AG; Clapp DW; Conway SJ; Guise TA; Yang FC
    PLoS One; 2011; 6(9):e24917. PubMed ID: 21980365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice.
    Chang T; Krisman K; Theobald EH; Xu J; Akutagawa J; Lauchle JO; Kogan S; Braun BS; Shannon K
    J Clin Invest; 2013 Jan; 123(1):335-9. PubMed ID: 23221337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2.
    Patrakitkomjorn S; Kobayashi D; Morikawa T; Wilson MM; Tsubota N; Irie A; Ozawa T; Aoki M; Arimura N; Kaibuchi K; Saya H; Araki N
    J Biol Chem; 2008 Apr; 283(14):9399-413. PubMed ID: 18218617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.
    Wang Y; Kim E; Wang X; Novitch BG; Yoshikawa K; Chang LS; Zhu Y
    Cell; 2012 Aug; 150(4):816-30. PubMed ID: 22901811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory role of stromal cell-derived factor-1 in bone morphogenetic protein-2-induced chondrogenic differentiation in vitro.
    Guang LG; Boskey AL; Zhu W
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1825-33. PubMed ID: 22771956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.
    Yang FC; Chen S; Robling AG; Yu X; Nebesio TD; Yan J; Morgan T; Li X; Yuan J; Hock J; Ingram DA; Clapp DW
    J Clin Invest; 2006 Nov; 116(11):2880-91. PubMed ID: 17053831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.
    Chen M; Lu L; Cheng D; Zhang J; Liu X; Zhang J; Zhang T
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.